Stock data
Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (SKYE) reported net income of -US$55.92M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$58.16M | -US$55.92M | — |
| 2024 | — | — | -US$30.19M | -US$26.57M | — |
| 2023 | — | — | -US$34.74M | -US$37.64M | — |
| 2022 | — | — | -US$18.31M | -US$19.48M | — |
| 2021 | — | — | -US$7.85M | -US$8.52M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$10.79M | — |
| 2026-03-31 | — | -US$12.51M | — |
| 2025-12-31 | — | -US$14.44M | — |
| 2025-09-30 | — | -US$12.75M | — |
| 2025-06-30 | — | -US$17.62M | — |
| 2025-03-31 | — | -US$11.10M | — |
| 2024-12-31 | — | -US$9.75M | — |
| 2024-09-30 | — | -US$3.90M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.